Laurence Leconte

Title: The Innovations of Laurence Leconte

Introduction

Laurence Leconte is a notable inventor based in Antony, France. He has made significant contributions to the field of biotechnology, particularly in the development of proteins and their applications in medicine. His work has the potential to impact various therapeutic areas.

Latest Patents

Laurence Leconte holds a patent for "Mutated netrin 4, fragments thereof and uses thereof as drugs." This patent includes proteins that have the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 4, along with fragments of these sequences. The protein fragments are represented by the sequences of SEQ ID NO: 2q, where q varies from 3 to 36, and the sequences of SEQ ID NO: 185 to SEQ ID NO: 209. Additionally, nucleotide sequences coding for these proteins are also provided. This innovation highlights the potential for new drug development based on these proteins.

Career Highlights

Throughout his career, Laurence Leconte has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Laurence has collaborated with notable colleagues, including Jean Plouët and Esma Lejmi. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.

Conclusion

Laurence Leconte's contributions to the field of biotechnology, particularly through his patent on mutated netrin 4, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in drug development.